MULTIMODAL RADIATION DIAGNOSIS OF BREAST CANCER
Main Article Content
Abstract
To date, one of the topical issues of modern oncology is the problem of breast cancer (BC), which ranks first in the structure of evilneoplasms in women. Every year, more than 1.5 million new cases of breast cancer are detected in the world, while more than 50% of women die from this pathology. According to the literature, the process of "rejuvenation" of breast cancer over the past decades has seen an increase in this disease among women at a younger age under 40 years [1]. In addition, breast cancer in young women may have a worse prognosis and more aggressive biological behavior than breast cancer in elderly patientsapprox. Previous studies have shown that in young women, breast cancer is diagnosed at a later stage, characterized by high proliferative activity, low differentiated Oh, with estrogen receptor negative tumors, with the presence of asular invasion lymphs [7; 10]. Previously, the definition of "young women" included patients under 35 years of age, since 2012, the World Health Organization has developed a new age classification [12], according to which: persons under the age of 44 are young; 45-59 years old - to mature; 60-74 years old to the elderly; 75-90 years old - to the elderly. The threshold of longevity is considered to be the achievement of 90 years or more.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Semiglazov V.F., Krivorotko P.V., Paltuev R.M. Book. Immunology of breast cancer // M.: SIMK, 2019. p.179-195.
An YY, Kim SH, Kang BJ. Breast cancer in very young women (<30 years): Correlation of imaging features with clinicopathological features and immunohistochemical subtypes // Eur J Radiol. 2015; 84:1894–1902.
An YY, Kim SH, Kang BJ. Characteristic features and usefulness of MRI in breast cancer in patients under 40 years old: correlations with conventional imaging and prognostic factors // Breast Cancer. 2014; 21:302–315.
Bird RE, Wallace TW, Yankaskas BC. Analysis of cancers missed at screening mammography // Radiology. 1992; 184:613–617.
Bullier B, MacGrogan G, Bonnefoi H, Hurtevent-Labrot G. Imaging features of sporadic breast cancer in women under 40 years old: 97 cases // Eur Radiol. 2013; 23:3237–3245.
Destounis S, Santacroce A. Age to Begin and Intervals for Breast Cancer Screening: Balancing Benefits and Harms // AJR Am J Roentgenol. 2018; 210:279–284.
Han W, Kim SW, Park IA, Kang D. Young age: an independent risk factor for disease-free survival in women with operable breast cancer // BMC Cancer. 2004; 4:82.
Freer PE. Mammographic breast density: impact on breast cancer risk and implications for screening // Radiographics. 2015; 35:302–315.
Fredholm H, Magnusson K, Lindström LS. Breast cancer in young women and prognosis: How important are proliferation markers? // Eur J Cancer. 2017; 84:278–289.
Fredholm H, Magnusson K, Lindström LS. Long-term outcome in young women with breast cancer: a population-based study // Breast Cancer Res Treat. 2016; 160:131–143.
Chang JM, Won JK, Lee KB. Comparison of shear-wave and strain ultrasound elastography in the differentiation of benign and malignant breast lesions // AJR Am J Roentgenol. 2013; 201: -Р. 347–356.
https://www.who.int.ru (2018)
Çelebi F, Pilancı KN, Ordu Ç. The role of ultrasonographic findings to predict molecular subtype, histologic grade, and hormone receptor status of breast cancer // Diagn Interv Radiol. 2015; 21:448–453.
Colleoni M, Rotmensz N, Robertson C, Orlando L. Very young women (<35 years) with operable breast cancer: features of disease at presentation // Ann Oncol. 2002; 13:273–279.
Gnerlich JL, Deshpande AD, Jeffe DB. Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease // J Am Coll Surg. 2009;208:341–347.
Lamb PM, Perry NM, Vinnicombe SJ. Correlation between ultrasound characteristics, mammographic findings and histological grade in patients with invasive ductal carcinoma of the breast // Clin Radiol. 2000; 55:40–44.
Oeffinger KC, Fontham ET, Etzioni R. Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update from the American Cancer Society // JAMA. 2015; 314:1599–1614.
Redmond CE, Healy GM, Murphy CF. The use of ultrasonography and digital mammography in women under 40 years with symptomatic breast cancer: a 7-year Irish experience // Ir J Med Sci. 2017; 186:63–67.
Yamada T, Mori N, Watanabe M. Radiologic-pathologic correlation of ductal carcinoma in situ // Radiographics. 2010; 30:1183–1198.